Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1314

1.

Zinc-oxide Nanoparticles Act Catalytically and Synergistically with Nitric Oxide Donors to Enhance Antimicrobial Efficacy.

Singha P, Workman CD, Pant J, Hopkins SP, Handa H.

J Biomed Mater Res A. 2019 Feb 8. doi: 10.1002/jbm.a.36657. [Epub ahead of print]

PMID:
30737882
2.

[Recurrence of acquired factor V inhibitor after four years of remission].

Akashi N, Ogawa Y, Yanagisawa K, Osaki Y, Shimizu H, Ishizaki T, Inoue M, Murakami M, Souri M, Ichinose A, Handa H.

Rinsho Ketsueki. 2019;60(1):46-50. doi: 10.11406/rinketsu.60.46. Japanese.

PMID:
30726824
3.

Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).

Murakami H, Kasamatsu T, Murakami J, Kiguchi T, Kanematsu T, Ogawa D, Takamatsu H, Handa H, Ozaki S, Miki H, Takahashi T, Takeo T, Yamauchi T, Morishita T, Kosugi H, Shimizu K.

Int J Hematol. 2019 Jan 31. doi: 10.1007/s12185-019-02607-z. [Epub ahead of print]

PMID:
30701467
4.

Correction to Tunable Nitric Oxide Release from S-Nitroso- N-acetylpenicillamine via Catalytic Copper Nanoparticles for Biomedical Applications.

Pant J, Goudie MJ, Hopkins SP, Brisbois EJ, Handa H.

ACS Appl Mater Interfaces. 2019 Jan 10. doi: 10.1021/acsami.8b22363. [Epub ahead of print] No abstract available.

PMID:
30629418
5.

Application of high-performance magnetic nanobeads to biological sensing devices.

Kabe Y, Sakamoto S, Hatakeyama M, Yamaguchi Y, Suematsu M, Itonaga M, Handa H.

Anal Bioanal Chem. 2019 Jan 9. doi: 10.1007/s00216-018-1548-y. [Epub ahead of print] Review.

PMID:
30627798
6.

Active Release of an Antimicrobial and Antiplatelet Agent from a Nonfouling Surface Modification.

Goudie MJ, Singha P, Hopkins SP, Brisbois EJ, Handa H.

ACS Appl Mater Interfaces. 2019 Jan 30;11(4):4523-4530. doi: 10.1021/acsami.8b16819. Epub 2019 Jan 16.

PMID:
30607929
7.

[Safety and management of adverse events of ixazomib/lenalidomide/dexamethasone therapy in Japanese patients with relapsed/refractory multiple myeloma].

Iida S, Izumi T, Aotsuka N, Komeno T, Ishida T, Sunami K, Handa H, Berg D, Kase Y, Soeda J.

Rinsho Ketsueki. 2018;59(11):2399-2407. doi: 10.11406/rinketsu.59.2399. Japanese.

PMID:
30531133
8.

Epithelial-specific histone modification of the miR-96/182 locus targeting AMAP1 mRNA predisposes p53 to suppress cell invasion in epithelial cells.

Handa H, Hashimoto A, Hashimoto S, Sugino H, Oikawa T, Sabe H.

Cell Commun Signal. 2018 Dec 4;16(1):94. doi: 10.1186/s12964-018-0302-6.

9.

Antithrombotic properties of hemofilter coated with polymer having a hydrophilic blood-contacting layer.

Tagaya M, Hara K, Takahashi S, Nagoshi S, Handa H, Okano S, Murataka T.

Int J Artif Organs. 2018 Nov 29:391398818815480. doi: 10.1177/0391398818815480. [Epub ahead of print]

10.

Prognostic impact of trisomy 21 in follicular lymphoma.

Mitsui T, Yokohama A, Koiso H, Saito A, Toyama K, Shimizu H, Ishizaki T, Irisawa H, Takizawa M, Saitoh T, Murayama K, Matsumoto M, Handa H, Hirato J, Kojima M, Murakami H, Tsukamoto N.

Br J Haematol. 2019 Feb;184(4):570-577. doi: 10.1111/bjh.15664. Epub 2018 Nov 12.

PMID:
30417943
11.

Clinical impact of serum soluble SLAMF7 in multiple myeloma.

Ishibashi M, Soeda S, Sasaki M, Handa H, Imai Y, Tanaka N, Tanosaki S, Ito S, Odajima T, Sugimori H, Asayama T, Sunakawa M, Kaito Y, Kinoshita R, Kuribayashi Y, Onodera A, Moriya K, Tanaka J, Tsukune Y, Komatsu N, Inokuchi K, Tamura H.

Oncotarget. 2018 Oct 5;9(78):34784-34793. doi: 10.18632/oncotarget.26196. eCollection 2018 Oct 5.

12.

Two Types of Volatile Polyenes in the Brown Alga Sargassum thunbergii.

Lu SJ, Yosemoto S, Satomi D, Handa H, Akakabe Y.

J Oleo Sci. 2018;67(11):1463-1471. doi: 10.5650/jos.ess17276.

13.

Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.

Matsuo H, Yoshida K, Fukumura K, Nakatani K, Noguchi Y, Takasaki S, Noura M, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Shiba N, Yamato G, Handa H, Ono Y, Hiramoto N, Ishikawa T, Usuki K, Ishiyama K, Miyawaki S, Itonaga H, Miyazaki Y, Kawamura M, Yamaguchi H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Hayashi Y, Mano H, Miyano S, Kamikubo Y, Ogawa S, Adachi S.

Blood Adv. 2018 Nov 13;2(21):2879-2889. doi: 10.1182/bloodadvances.2018019398.

14.

Structural features of two major nucleolar organizer regions (NORs), Nor-B1 and Nor-B2, and chromosome-specific rRNA gene expression in wheat.

Handa H, Kanamori H, Tanaka T, Murata K, Kobayashi F, Robinson SJ, Koh CS, Pozniak CJ, Sharpe AG, Paux E; International Wheat Genome Sequencing Consortium, Wu J, Nasuda S.

Plant J. 2018 Dec;96(6):1148-1159. doi: 10.1111/tpj.14094. Epub 2018 Oct 27.

PMID:
30238531
15.

Antibacterial 3D bone scaffolds for tissue engineering application.

Pant J, Sundaram J, Goudie MJ, Nguyen DT, Handa H.

J Biomed Mater Res B Appl Biomater. 2018 Sep 19. doi: 10.1002/jbm.b.34199. [Epub ahead of print]

PMID:
30230685
16.

Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy.

Tsukamoto N, Yokohama A, Higuchi T, Mitsui T, Koiso H, Takizawa M, Shimizu H, Ishizaki T, Matsumoto M, Toyama K, Sakura T, Ogura H, Saitoh T, Ishida F, Murakami H, Tsushima Y, Handa H.

Int J Hematol. 2019 Jan;109(1):91-97. doi: 10.1007/s12185-018-2526-z. Epub 2018 Sep 10.

PMID:
30203253
17.

Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma.

Kasamatsu T, Ozaki S, Saitoh T, Konishi J, Sunami K, Itagaki M, Asaoku H, Cho T, Handa H, Hagiwara S, Wakayama T, Negoro A, Takezako N, Harada N, Kuroda Y, Nakaseko C, Miyake T, Inoue N, Hata H, Shimazaki C, Ohno T, Kuroda J, Murayama T, Kobayashi T, Abe M, Ishida T, Nagura E, Shimizu K.

Hematol Oncol. 2018 Dec;36(5):792-800. doi: 10.1002/hon.2559. Epub 2018 Sep 19.

PMID:
30176173
18.

Clear cell myoepithelial carcinoma involving vestibule and alveolus: A rare case report with review of literature.

Gupta AA, Khare P, Jain M, Handa H.

J Oral Maxillofac Pathol. 2018 May-Aug;22(2):245-248. doi: 10.4103/jomfp.JOMFP_10_18.

19.

3D-measurement of tracheobronchial angles on inspiratory and expiratory chest CT in COPD: respiratory changes and correlation with airflow limitation.

Onoe R, Yamashiro T, Handa H, Azagami S, Matsuoka S, Inoue T, Miyazawa T, Mineshita M.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 10;13:2399-2407. doi: 10.2147/COPD.S165824. eCollection 2018.

20.

Shifting the limits in wheat research and breeding using a fully annotated reference genome.

International Wheat Genome Sequencing Consortium (IWGSC); IWGSC RefSeq principal investigators:, Appels R, Eversole K, Feuillet C, Keller B, Rogers J, Stein N; IWGSC whole-genome assembly principal investigators:, Pozniak CJ, Stein N, Choulet F, Distelfeld A, Eversole K, Poland J, Rogers J, Ronen G, Sharpe AG; Whole-genome sequencing and assembly:, Pozniak C, Ronen G, Stein N, Barad O, Baruch K, Choulet F, Keeble-Gagnère G, Mascher M, Sharpe AG, Ben-Zvi G, Josselin AA; Hi-C data-based scaffolding:, Stein N, Mascher M, Himmelbach A; Whole-genome assembly quality control and analyses:, Choulet F, Keeble-Gagnère G, Mascher M, Rogers J, Balfourier F, Gutierrez-Gonzalez J, Hayden M, Josselin AA, Koh C, Muehlbauer G, Pasam RK, Paux E, Pozniak CJ, Rigault P, Sharpe AG, Tibbits J, Tiwari V; Pseudomolecule assembly:, Choulet F, Keeble-Gagnère G, Mascher M, Josselin AA, Rogers J; RefSeq genome structure and gene analyses:, Spannagl M, Choulet F, Lang D, Gundlach H, Haberer G, Keeble-Gagnère G, Mayer KFX, Ormanbekova D, Paux E, Prade V, Šimková H, Wicker T; Automated annotation:, Choulet F, Spannagl M, Swarbreck D, Rimbert H, Felder M, Guilhot N, Gundlach H, Haberer G, Kaithakottil G, Keilwagen J, Lang D, Leroy P, Lux T, Mayer KFX, Twardziok S, Venturini L; Manual gene curation:, Appels R, Rimbert H, Choulet F, Juhász A, Keeble-Gagnère G; Subgenome comparative analyses:, Choulet F, Spannagl M, Lang D, Abrouk M, Haberer G, Keeble-Gagnère G, Mayer KFX, Wicker T; Transposable elements:, Choulet F, Wicker T, Gundlach H, Lang D, Spannagl M; Phylogenomic analyses:, Lang D, Spannagl M, Appels R, Fischer I; Transcriptome analyses and RNA-seq data:, Uauy C, Borrill P, Ramirez-Gonzalez RH, Appels R, Arnaud D, Chalabi S, Chalhoub B, Choulet F, Cory A, Datla R, Davey MW, Hayden M, Jacobs J, Lang D, Robinson SJ, Spannagl M, Steuernagel B, Tibbits J, Tiwari V, van Ex F, Wulff BBH; Whole-genome methylome:, Pozniak CJ, Robinson SJ, Sharpe AG, Cory A; Histone mark analyses:, Benhamed M, Paux E, Bendahmane A, Concia L, Latrasse D; BAC chromosome MTP IWGSC–Bayer Whole-Genome Profiling (WGP) tags:, Rogers J, Jacobs J, Alaux M, Appels R, Bartoš J, Bellec A, Berges H, Doležel J, Feuillet C, Frenkel Z, Gill B, Korol A, Letellier T, Olsen OA, Šimková H, Singh K, Valárik M, van der Vossen E, Vautrin S, Weining S; Chromosome LTC mapping and physical mapping quality control:, Korol A, Frenkel Z, Fahima T, Glikson V, Raats D, Rogers J; RH mapping:, Tiwari V, Gill B, Paux E, Poland J; Optical mapping:, Doležel J, Číhalíková J, Šimková H, Toegelová H, Vrána J; Recombination analyses:, Sourdille P, Darrier B; Gene family analyses:, Appels R, Spannagl M, Lang D, Fischer I, Ormanbekova D, Prade V; CBF gene family:, Barabaschi D, Cattivelli L; Dehydrin gene family:, Hernandez P, Galvez S, Budak H; NLR gene family:, Steuernagel B, Jones JDG, Witek K, Wulff BBH, Yu G; PPR gene family:, Small I, Melonek J, Zhou R; Prolamin gene family:, Juhász A, Belova T, Appels R, Olsen OA; WAK gene family:, Kanyuka K, King R; Stem solidness (SSt1) QTL team:, Nilsen K, Walkowiak S, Pozniak CJ, Cuthbert R, Datla R, Knox R, Wiebe K, Xiang D; Flowering locus C (FLC) gene team:, Rohde A, Golds T; Genome size analysis:, Doležel J, Čížková J, Tibbits J; MicroRNA and tRNA annotation:, Budak H, Akpinar BA, Biyiklioglu S; Genetic maps and mapping:, Muehlbauer G, Poland J, Gao L, Gutierrez-Gonzalez J, N'Daiye A; BAC libraries and chromosome sorting:, Doležel J, Šimková H, Číhalíková J, Kubaláková M, Šafář J, Vrána J; BAC pooling, BAC library repository, and access:, Berges H, Bellec A, Vautrin S; IWGSC sequence and data repository and access:, Alaux M, Alfama F, Adam-Blondon AF, Flores R, Guerche C, Letellier T, Loaec M, Quesneville H; Physical maps and BAC-based sequences:; 1A BAC sequencing and assembly:, Pozniak CJ, Sharpe AG, Walkowiak S, Budak H, Condie J, Ens J, Koh C, Maclachlan R, Tan Y, Wicker T; 1B BAC sequencing and assembly:, Choulet F, Paux E, Alberti A, Aury JM, Balfourier F, Barbe V, Couloux A, Cruaud C, Labadie K, Mangenot S, Wincker P; 1D, 4D, and 6D physical mapping:, Gill B, Kaur G, Luo M, Sehgal S; 2AL physical mapping:, Singh K, Chhuneja P, Gupta OP, Jindal S, Kaur P, Malik P, Sharma P, Yadav B; 2AS physical mapping:, Singh NK, Khurana J, Chaudhary C, Khurana P, Kumar V, Mahato A, Mathur S, Sevanthi A, Sharma N, Tomar RS; 2B, 2D, 4B, 5BL, and 5DL IWGSC–Bayer Whole-Genome Profiling (WGP) physical maps:, Rogers J, Jacobs J, Alaux M, Bellec A, Berges H, Doležel J, Feuillet C, Frenkel Z, Gill B, Korol A, van der Vossen E, Vautrin S; 3AL physical mapping:, Gill B, Kaur G, Luo M, Sehgal S; 3DS physical mapping and BAC sequencing and assembly:, Bartoš J, Holušová K, Plíhal O; 3DL BAC sequencing and assembly:, Clark MD, Heavens D, Kettleborough G, Wright J; 4A physical mapping, BAC sequencing, assembly, and annotation:, Valárik M, Abrouk M, Balcárková B, Holušová K, Hu Y, Luo M; 5BS BAC sequencing and assembly:, Salina E, Ravin N, Skryabin K, Beletsky A, Kadnikov V, Mardanov A, Nesterov M, Rakitin A, Sergeeva E; 6B BAC sequencing and assembly:, Handa H, Kanamori H, Katagiri S, Kobayashi F, Nasuda S, Tanaka T, Wu J; 7A physical mapping and BAC sequencing:, Appels R, Hayden M, Keeble-Gagnère G, Rigault P, Tibbits J; 7B physical mapping, BAC sequencing, and assembly:, Olsen OA, Belova T, Cattonaro F, Jiumeng M, Kugler K, Mayer KFX, Pfeifer M, Sandve S, Xun X, Zhan B; 7DS BAC sequencing and assembly:, Šimková H, Abrouk M, Batley J, Bayer PE, Edwards D, Hayashi S, Toegelová H, Tulpová Z, Visendi P; 7DL physical mapping and BAC sequencing:, Weining S, Cui L, Du X, Feng K, Nie X, Tong W, Wang L; Figures:, Borrill P, Gundlach H, Galvez S, Kaithakottil G, Lang D, Lux T, Mascher M, Ormanbekova D, Prade V, Ramirez-Gonzalez RH, Spannagl M, Stein N, Uauy C, Venturini L; Manuscript writing team:, Stein N, Appels R, Eversole K, Rogers J, Borrill P, Cattivelli L, Choulet F, Hernandez P, Kanyuka K, Lang D, Mascher M, Nilsen K, Paux E, Pozniak CJ, Ramirez-Gonzalez RH, Šimková H, Small I, Spannagl M, Swarbreck D, Uauy C.

Science. 2018 Aug 17;361(6403). pii: eaar7191. doi: 10.1126/science.aar7191. Epub 2018 Aug 16.

PMID:
30115783
21.

Function and structural regulation of the carbon monoxide (CO)-responsive membrane protein PGRMC1.

Kabe Y, Handa H, Suematsu M.

J Clin Biochem Nutr. 2018 Jul;63(1):12-17. doi: 10.3164/jcbn.17-132. Epub 2018 Apr 11. Review.

22.

A novel CYCS mutation in the α-helix of the CYCS C-terminal domain causes non-syndromic thrombocytopenia.

Uchiyama Y, Yanagisawa K, Kunishima S, Shiina M, Ogawa Y, Nakashima M, Hirato J, Imagawa E, Fujita A, Hamanaka K, Miyatake S, Mitsuhashi S, Takata A, Miyake N, Ogata K, Handa H, Matsumoto N, Mizuguchi T.

Clin Genet. 2018 Dec;94(6):548-553. doi: 10.1111/cge.13423. Epub 2018 Sep 3.

PMID:
30051457
23.

Achieving Long-Term Biocompatible Silicone via Covalently Immobilized S-Nitroso- N-acetylpenicillamine (SNAP) That Exhibits 4 Months of Sustained Nitric Oxide Release.

Hopkins SP, Pant J, Goudie MJ, Schmiedt C, Handa H.

ACS Appl Mater Interfaces. 2018 Aug 15;10(32):27316-27325. doi: 10.1021/acsami.8b08647. Epub 2018 Aug 1.

PMID:
30028941
24.

Development of a Highly Sensitive Device for Counting the Number of Disease-Specific Exosomes in Human Sera.

Kabe Y, Suematsu M, Sakamoto S, Hirai M, Koike I, Hishiki T, Matsuda A, Hasegawa Y, Tsujita K, Ono M, Minegishi N, Hozawa A, Murakami Y, Kubo M, Itonaga M, Handa H.

Clin Chem. 2018 Oct;64(10):1463-1473. doi: 10.1373/clinchem.2018.291963. Epub 2018 Jul 18.

PMID:
30021922
25.

NQO1 inhibits the TLR-dependent production of selective cytokines by promoting IκB-ζ degradation.

Kimura A, Kitajima M, Nishida K, Serada S, Fujimoto M, Naka T, Fujii-Kuriyama Y, Sakamato S, Ito T, Handa H, Tanaka T, Yoshimura A, Suzuki H.

J Exp Med. 2018 Aug 6;215(8):2197-2209. doi: 10.1084/jem.20172024. Epub 2018 Jun 22.

26.

Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols.

Kato H, Fujita H, Akiyama N, Kimura SI, Hiramoto N, Hosono N, Takahashi T, Shigeno K, Minamiguchi H, Miyatake J, Handa H, Kanda Y, Yoshida M, Miyawaki S, Ohtake S, Naoe T, Kiyoi H, Matsumura I, Miyazaki Y; Japan Adult Leukemia Study Group.

Support Care Cancer. 2018 Dec;26(12):4187-4198. doi: 10.1007/s00520-018-4292-0. Epub 2018 Jun 2.

PMID:
29860713
27.

[Congenital factor V and factor VIII deficiency discovered in an elderly patient with abnormal bleeding after trauma].

Ogawa Y, Yanagisawa K, Uchiyama Y, Matsumoto A, Inoue M, Toyama K, Miyazawa Y, Matsumoto N, Handa H.

Rinsho Ketsueki. 2018;59(4):383-388. doi: 10.11406/rinketsu.59.383. Japanese.

PMID:
29743396
28.

Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia.

Gotoh N, Saitoh T, Takahashi N, Kasamatsu T, Minato Y, Lobna A, Oda T, Hoshino T, Sakura T, Shimizu H, Takizawa M, Handa H, Yokohama A, Tsukamoto N, Murakami H.

Int J Hematol. 2018 Sep;108(3):246-253. doi: 10.1007/s12185-018-2464-9. Epub 2018 May 8.

PMID:
29737460
29.

Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients.

Nagano D, Araki T, Yanagisawa K, Ogawa Y, Gohda F, Uchiumi H, Handa H, Nakamura T, Yamamoto K.

Eur J Clin Pharmacol. 2018 Aug;74(8):1055-1060. doi: 10.1007/s00228-018-2464-y. Epub 2018 May 2.

PMID:
29721582
30.

Successful hemostatic management of major surgery for cervical spondylotic myelopathy in a patient with severe factor XI deficiency.

Ogawa Y, Yanagisawa K, Uchiyama Y, Akashi N, Mieda T, Iizuka H, Inoue M, Shizuka R, Murakami M, Matsumoto N, Handa H.

Int J Hematol. 2018 Oct;108(4):443-446. doi: 10.1007/s12185-018-2462-y. Epub 2018 Apr 30.

PMID:
29713955
31.

Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan.

Noguchi S, Nakaseko C, Nishiwaki K, Ogasawara H, Ohishi K, Tokuhira M, Noguchi M, Kimura H, Handa H, Mitani K, Miura M, Wakita H, Takahashi N; STAT study group.

Int J Hematol. 2018 Aug;108(2):176-183. doi: 10.1007/s12185-018-2459-6. Epub 2018 Apr 30.

PMID:
29713954
32.

Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma.

Higuchi H, Yamakawa N, Imadome KI, Yahata T, Kotaki R, Ogata J, Kakizaki M, Fujita K, Lu J, Yokoyama K, Okuyama K, Sato A, Takamatsu M, Kurosaki N, Alba SM, Azhim A, Horie R, Watanabe T, Kitamura T, Ando K, Kashiwagi T, Matsui T, Okamoto A, Handa H, Kuroda M, Nakamura N, Kotani A.

Blood. 2018 Jun 7;131(23):2552-2567. doi: 10.1182/blood-2017-07-794529. Epub 2018 Apr 22.

PMID:
29685921
33.

[Giant hemophilic pseudotumors in brothers with non-severe hemophilia B].

Matsumura I, Yanagisawa K, Ogawa Y, Shimizu H, Ishizaki T, Mitsui T, Uchiumi H, Uchiyama Y, Matsumuto N, Handa H.

Rinsho Ketsueki. 2018;59(3):287-292. doi: 10.11406/rinketsu.59.287. Japanese.

PMID:
29618686
34.

Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial.

Isoda A, Murayama K, Ito S, Kohara Y, Iino M, Miyazawa Y, Matsumoto M, Handa H, Imai Y, Ishiguro T, Izumita W, Kitano K, Hirabayashi Y, Nakazawa H, Ishida F, Mitsumori T, Kirito K, Chou T, Murakami H; Kanshinetsu Multiple Myeloma Study Group.

Int J Hematol. 2018 Jul;108(1):39-46. doi: 10.1007/s12185-018-2448-9. Epub 2018 Mar 28.

PMID:
29594921
35.

Short-term administration of recombinant human erythropoietin decreases B cell number in human peripheral blood.

Nagashima T, Yokohama A, Nagai K, Kasamatsu T, Gotoh N, Iriuchishima H, Sekigami T, Saitoh T, Handa H, Tsukamoto N, Murakami H.

Transfus Apher Sci. 2018 Apr;57(2):208-214. doi: 10.1016/j.transci.2018.01.009. Epub 2018 Feb 2.

PMID:
29439918
36.

Clinical management and outcomes of completely resected stage I follicular lymphoma.

Yokohama A, Hashimoto Y, Takizawa M, Shimizu H, Miyazawa Y, Saitoh A, Toyama K, Ishizaki T, Mitsui T; Hiromi; Koiso, Saitoh T, Murayama K, Matsumoto M, Sawamura M, Murakami H, Hirato J, Kojima M, Nojima Y, Handa H, Tsukamoto N.

J Clin Exp Hematop. 2018 Mar 16;58(1):10-16. doi: 10.3960/jslrt.17031. Epub 2018 Feb 8.

37.

Nitric oxide-releasing antibacterial albumin plastic for biomedical applications.

Jones A, Pant J, Lee E, Goudie MJ, Gruzd A, Mansfield J, Mandal A, Sharma S, Handa H.

J Biomed Mater Res A. 2018 Jun;106(6):1535-1542. doi: 10.1002/jbm.a.36349. Epub 2018 Feb 19.

PMID:
29377589
38.

Necessity of p53-binding to the CDH1 locus for its expression defines two epithelial cell types differing in their integrity.

Oikawa T, Otsuka Y, Onodera Y, Horikawa M, Handa H, Hashimoto S, Suzuki Y, Sabe H.

Sci Rep. 2018 Jan 25;8(1):1595. doi: 10.1038/s41598-018-20043-7.

39.

PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia.

Kasamatsu T, Ino R, Takahashi N, Gotoh N, Minato Y, Takizawa M, Yokohama A, Handa H, Saitoh T, Tsukamoto N, Murakami H.

Br J Haematol. 2018 Mar;180(5):705-714. doi: 10.1111/bjh.15085. Epub 2018 Jan 23.

PMID:
29359792
40.

Structural basis of thalidomide enantiomer binding to cereblon.

Mori T, Ito T, Liu S, Ando H, Sakamoto S, Yamaguchi Y, Tokunaga E, Shibata N, Handa H, Hakoshima T.

Sci Rep. 2018 Jan 22;8(1):1294. doi: 10.1038/s41598-018-19202-7.

41.

Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.

Otsuka Y, Oikawa T, Yoshino H, Hashimoto S, Handa H, Yamamoto H, Hashimoto A, Sabe H.

Cell Commun Signal. 2018 Jan 5;16(1):1. doi: 10.1186/s12964-017-0212-z.

42.

Biotemplated Synthesis and Characterization of Mesoporous Nitric Oxide-Releasing Diatomaceous Earth Silica Particles.

Grommersch BM, Pant J, Hopkins SP, Goudie MJ, Handa H.

ACS Appl Mater Interfaces. 2018 Jan 24;10(3):2291-2301. doi: 10.1021/acsami.7b15967. Epub 2018 Jan 11.

PMID:
29278482
43.

Nitric oxide releasing vascular catheters for eradicating bacterial infection.

Pant J, Goudie MJ, Chaji SM, Johnson BW, Handa H.

J Biomed Mater Res B Appl Biomater. 2018 Nov;106(8):2849-2857. doi: 10.1002/jbm.b.34065. Epub 2017 Dec 20.

PMID:
29266734
44.

Computer-Aided Diagnosis Based on Convolutional Neural Network System for Colorectal Polyp Classification: Preliminary Experience.

Komeda Y, Handa H, Watanabe T, Nomura T, Kitahashi M, Sakurai T, Okamoto A, Minami T, Kono M, Arizumi T, Takenaka M, Hagiwara S, Matsui S, Nishida N, Kashida H, Kudo M.

Oncology. 2017;93 Suppl 1:30-34. doi: 10.1159/000481227. Epub 2017 Dec 20.

45.

Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis.

Oritani K, Ohishi K, Okamoto S, Kirito K, Komatsu N, Tauchi T, Handa H, Saito S, Takenaka K, Shimoda K, Okada H, Amagasaki T, Wakase S, Shimozuma K, Akashi K.

Curr Med Res Opin. 2018 Mar;34(3):531-537. doi: 10.1080/03007995.2017.1415874. Epub 2018 Jan 4.

PMID:
29224367
46.

A Rare Case of Chronic Active Epstein-Barr Virus (EBV) Infection Accompanied by the Infiltration of EBV-infected CD8+ T Cells into the Muscle.

Kobayashi N, Mitsui T, Ogawa Y, Iriuchishima H, Takizawa M, Yokohama A, Saitoh T, Koiso H, Tsukamoto N, Murakami H, Nojima Y, Handa H.

J Pediatr Hematol Oncol. 2018 Apr;40(3):e171-e175. doi: 10.1097/MPH.0000000000001026.

PMID:
29200172
47.

Assessment of Bronchial Obstruction Using Lateral Pressure Measurement during Bronchoscopy.

Nishine H, Hiramoto T, Inoue T, Furuya N, Kida H, Handa H, Nobuyama S, Mineshita M, Miyazawa T.

Respiration. 2018;95(2):106-113. doi: 10.1159/000481572. Epub 2017 Nov 30.

48.

Implementation of pulse timing discriminator functionality into a GeSbTe/GeCuTe double layer structure.

Akimoto R, Handa H, Shindo S, Sutou Y, Kuwahara M, Naruse M, Saiki T.

Opt Express. 2017 Oct 30;25(22):26825-26831. doi: 10.1364/OE.25.026825.

PMID:
29092167
49.

Covalent Grafting of Antifouling Phosphorylcholine-Based Copolymers with Antimicrobial Nitric Oxide Releasing Polymers to Enhance Infection-Resistant Properties of Medical Device Coatings.

Liu Q, Singha P, Handa H, Locklin J.

Langmuir. 2017 Nov 14;33(45):13105-13113. doi: 10.1021/acs.langmuir.7b02970. Epub 2017 Oct 30.

PMID:
29083929
50.

Liquid-infused nitric oxide-releasing (LINORel) silicone for decreased fouling, thrombosis, and infection of medical devices.

Goudie MJ, Pant J, Handa H.

Sci Rep. 2017 Oct 19;7(1):13623. doi: 10.1038/s41598-017-14012-9.

Supplemental Content

Support Center